Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

→ **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad)
Free NTRB Stock Alerts
$4.61
+0.14 (+3.13%)
(As of 12:10 PM ET)
Compare
Today's Range
$4.40
▼
$4.86
50-Day Range
$2.30
▼
$5.06
52-Week Range
$1.53
▼
$6.00
Volume
18,430 shs
Average Volume
36,294 shs
Market Capitalization
$50.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media
NTRB stock logo

About Nutriband Stock (NASDAQ:NTRB)

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

NTRB Stock Price History

NTRB Stock News Headlines

May 16, 2024 | finanznachrichten.de
Nutriband Inc.: Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
May 8, 2024 | theglobeandmail.com
Nutriband’s (NASDAQ: NTRB) Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA Approval
April 25, 2024 | finance.yahoo.com
IBN Coverage Initiated for Nutriband Inc.
April 24, 2024 | finanznachrichten.de
Nutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA Submission
April 24, 2024 | finance.yahoo.com
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
April 21, 2024 | uk.investing.com
Nutriband closes funding for abuse-deterrent fentanyl patch
April 1, 2024 | finance.yahoo.com
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
March 28, 2024 | marketwatch.com
Nutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA Submission
March 27, 2024 | benzinga.com
Gerald Goodman's Net Worth
March 27, 2024 | finanznachrichten.de
Nutriband Inc.: Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA Fentanyl Transdermal Patch
March 27, 2024 | finance.yahoo.com
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
January 29, 2024 | finance.yahoo.com
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st
January 26, 2024 | finanznachrichten.de
Nutriband Inc.: Nutriband CEO Publishes Letter to Shareholders
January 26, 2024 | finance.yahoo.com
Nutriband CEO Publishes Letter to Shareholders
January 5, 2024 | finance.yahoo.com
Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
December 29, 2023 | morningstar.com
Nutriband Inc NTRB
December 18, 2023 | investorplace.com
NTRB Stock Earnings: Nutriband Reported Results for Q3 2023
November 28, 2023 | finance.yahoo.com
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling
November 28, 2023 | finance.yahoo.com
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling
October 11, 2023 | finance.yahoo.com
Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm
September 20, 2023 | finanznachrichten.de
Financialnewsmedia.com: Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
September 20, 2023 | finanznachrichten.de
Nutriband Inc.: Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
September 20, 2023 | finance.yahoo.com
Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
September 20, 2023 | finance.yahoo.com
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
September 12, 2023 | finance.yahoo.com
Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023
See More Headlines

Company Calendar

Last Earnings
4/30/2024
Today
5/20/2024
Next Earnings (Estimated)
6/14/2024
Fiscal Year End
1/31/2025
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NTRB
CUSIP
N/A
CIK
1676047
Web
nutriband.com
Phone
(407) 377-6695
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,490,000.00
Net Margins
-262.94%
Pretax Margin
-263.07%
Return on Equity
-73.71%
Return on Assets
-57.02%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.02
Quick Ratio
0.85

Sales & Book Value

Annual Sales
$2.09 million
Price / Sales
24.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.73 per share
Price / Book
6.32

Miscellaneous

Outstanding Shares
10,970,000
Free Float
6,236,000
Market Cap
$50.57 million
Optionable
Not Optionable
Beta
0.97

Key Executives

  • Mr. Serguei Melnik (Age 50)
    Founder, President, Company Secretary & Executive Chairman of the Board
    Comp: $200k
  • Mr. Gareth Sheridan (Age 34)
    Founder, CEO & Director
    Comp: $200k
  • Mr. Gerald Goodman (Age 76)
    CFO & Chief Accounting Officer
    Comp: $160k
  • Dr. Alan Smith Ph.D. (Age 58)
    COO & President of 4P Therapeutics
    Comp: $179k
  • Mr. Patrick Ryan (Age 38)
    Chief Technical Officer
  • Dr. Jeffrey Patrick Pharm.D. (Age 54)
    Chief Scientific Officer
  • Mr. Tyler Overk (Age 40)
    President of Active Intelligence

Key Competitors

View All Competitors

NTRB Stock Analysis - Frequently Asked Questions

How have NTRB shares performed in 2024?

Nutriband's stock was trading at $2.32 at the start of the year. Since then, NTRB stock has increased by 98.7% and is now trading at $4.61.
View the best growth stocks for 2024 here.

When is Nutriband's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, June 14th 2024.
View our NTRB earnings forecast.

How were Nutriband's earnings last quarter?

Nutriband Inc. (NASDAQ:NTRB) released its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.16) earnings per share (EPS) for the quarter. The business earned $0.53 million during the quarter. Nutriband had a negative trailing twelve-month return on equity of 73.71% and a negative net margin of 262.94%.

When did Nutriband's stock split?

Shares of Nutriband split on Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly issued shares were distributed to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

How do I buy shares of Nutriband?

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NTRB) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Elon to Transform U.S. Economy?
Porter & Company
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
"The Biggest Drug Ever" Is Coming
Behind the Markets
Most important medical advance in 100 years
The Oxford Club
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star